Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures (Schedule of Segment Reporting Information) (Details)

v2.4.0.8
Segment Disclosures (Schedule of Segment Reporting Information) (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Segment Reporting Information [Line Items]        
Revenue $ 1,588,183 $ 833,764 $ 3,846,947 $ 2,514,005
Cost of revenue 1,108,394 533,043 2,842,087 1,793,808
Gross profit 479,789 300,721 1,004,860 720,197
Engineering Services [Member]
       
Segment Reporting Information [Line Items]        
Revenue 799,884 417,082 1,841,355 1,375,010
Cost of revenue 529,657 287,468 1,431,802 1,018,801
Gross profit 270,227 129,614 409,553 356,209
Medical Devices [Member]
       
Segment Reporting Information [Line Items]        
Revenue 788,299 416,682 2,005,592 1,138,995
Cost of revenue 578,737 245,575 1,410,285 775,007
Gross profit $ 209,562 $ 171,107 $ 595,307 $ 363,988